![](/img/cover-not-exists.png)
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
Lacouture, M. E., Keefe, D. M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J. P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B., Garon, E. B.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw227
Date:
September, 2016
File:
PDF, 213 KB
english, 2016